Questions and answers on the use of Product Lifecycle Management (PLCM) document - Scientific guideline

26 January 2026

SPOR and XEVMPD status update webinar - Q1 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 28 January 2026, 10:00 (CET) to 28 January 2026, 12:30 (CET)

26 January 2026

Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation: 12/11/2021, Revision: 9, Status: Withdrawn

23 January 2026

Human medicines European public assessment report (EPAR): Austedo, deutetrabenazine, Date of authorisation: 08/01/2026, Status: Authorised

23 January 2026

Human medicines European public assessment report (EPAR): Nexviadyme, avalglucosidase alfa, Date of authorisation: 24/06/2022, Revision: 6, Status: Authorised

23 January 2026

Human medicines European public assessment report (EPAR): Travatan, travoprost, Date of authorisation: 27/11/2001, Revision: 32, Status: Authorised

23 January 2026

European Medicines Agency’s data protection notice for EudraVigilance Human (EV)

23 January 2026

Joint controllership arrangement with regard to EudraVigilance Human (EV)

23 January 2026

SMS guidance for external users

23 January 2026

PRAC work plan 2026

23 January 2026